May 2020 FDA Recall Doxycycline Hyclate by West-ward Columbus Inc
D-1274-2020 - Failed dissolution specification

This Class II drug recall was voluntarily initiated by West-ward Columbus Inc on May 13, 2020 for the product Doxycycline Hyclate. The FDA reported the reason for recall as failed dissolution specification. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1274-2020

Reason for Recall
Failed dissolution specification: The dissolution test at the 24 month time point (end of shelf life) yielded an out of specification result.
Initiated
05-13-2020
Reported
06-03-2020
Quantity
68,376 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
West-Ward Columbus Inc
Doxycycline Hyclate Tablets USP, 100 mg, packaged in a) 50-count bottle (NDC 0143-2112-50), b) 500-count bottle (NDC 0143-2112-05), Rx only, Mfd. by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724.

Batch or Lot Expiration Information

Lot# : a) 71846B, Exp 6/2021; b) 71726A, Exp 6/2020; 71846B, 71853A, Exp 6/2021